C. Fang

New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy

Shenhong Wu, K. Zarrabi, C. Fang, 2017, Journal of Hematology & Oncology.

65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research

W. Zheng, X. Wang, Y. Xin, 2021, Annals of Oncology.